Determination of a Phase II Dose of Panobinostat in Combination with 5-Azacitidine in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

被引：0
|
作者：
Ottmann, Oliver G. [1 ]
DeAngelo, Daniel J. [2 ]
Garcia-Manero, Guillermo [3 ]
Luebbert, Michael [4 ]
Jillella, Anand [5 ]
Sekeres, Mikkael A. [6 ]
Zahlten, Anita [7 ]
Squier, Margaret [8 ]
Acharyya, Suddhasatta [8 ]
Winiger, Ivo J. [7 ]
Fenaux, Pierre [9 ]
机构：
[1] Goethe Univ Frankfurt, Dept Internal Med, Frankfurt, Germany
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Univ Freiburg, D-79106 Freiburg, Germany
[5] Georgia Hlth Sci Univ, Augusta, GA USA
[6] Cleveland Clin, Cleveland, OH 44106 USA
[7] Novartis Pharma AG, Basel, Switzerland
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Hop Avicenne, AP HP, F-93009 Bobigny, France
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：212 / 213
页数：2
相关论文
共 50 条
  • [1] 5-Azacitidine Therapy in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia: a Single Institution Experience
    Freyrie, Alessandra
    Reda, Gianluigi
    Vincenti, Daniele
    Sciume, Mariarita
    Binda, Francesca
    Guidotti, Francesca
    Cortelezzi, Agostino
    BLOOD, 2012, 120 (21)
  • [2] Results of 5-azacitidine therapy in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML)
    Freyrie, A.
    Reda, G.
    Vincenti, D.
    Ferla, V.
    Orofino, N.
    Sciume, M.
    Guidotti, F.
    Cortelezzi, A.
    LEUKEMIA RESEARCH, 2013, 37 : S157 - S158
  • [3] Phase I study of panobinostat and 5-azacitidine in Japanese patients with myelodysplastic syndrome or chronic myelomonocytic leukemia
    Kobayashi, Yukio
    Munakata, Wataru
    Ogura, Michinori
    Uchida, Toshiki
    Taniwaki, Masafumi
    Kobayashi, Tsutomu
    Shimada, Fumika
    Yonemura, Masataka
    Matsuoka, Fumiko
    Tajima, Takeshi
    Yakushijin, Kimikazu
    Minami, Hironobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (01) : 83 - 91
  • [4] Phase I study of panobinostat and 5-azacitidine in Japanese patients with myelodysplastic syndrome or chronic myelomonocytic leukemia
    Yukio Kobayashi
    Wataru Munakata
    Michinori Ogura
    Toshiki Uchida
    Masafumi Taniwaki
    Tsutomu Kobayashi
    Fumika Shimada
    Masataka Yonemura
    Fumiko Matsuoka
    Takeshi Tajima
    Kimikazu Yakushijin
    Hironobu Minami
    International Journal of Hematology, 2018, 107 : 83 - 91
  • [5] Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
    Garcia-Manero, Guillermo
    Gore, Steven D.
    Cogle, Christopher
    Ward, Renee
    Shi, Tao
    MacBeth, Kyle J.
    Laille, Eric
    Giordano, Heidi
    Sakoian, Sarah
    Jabbour, Elias
    Kantarjian, Hagop
    Skikne, Barry
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18) : 2521 - 2527
  • [6] Leukemia cutis in myelodysplastic syndrome and chronic myelomonocytic leukemia patients treated with adjusted dose 5-azacitidine
    Stefania Infante, Maria
    Munoz, Carolina
    Heras, Cecilia
    Angeles Foncillas, Maria
    Gonzalez, Isabel
    Lucea, Irene
    Echavarria, Eva
    Aramendi, Teresa
    Angel Hernandez, Jose
    EUROPEAN JOURNAL OF DERMATOLOGY, 2015, 25 (06) : 622 - 623
  • [7] Leukemia cutis in myelodysplastic syndrome and chronic myelomonocytic leukemia patients treated with adjusted dose 5-azacitidine
    María Stefania Infante
    Carolina Muñoz
    Cecilia Heras
    María Angeles Foncillas
    Isabel González
    Irene Lucea
    Eva Echavarria
    Teresa Aramendi
    José Angel Hernández
    European Journal of Dermatology, 2015, 25 : 622 - 623
  • [8] Azacitidine access program for Belgian patients with myelodysplastic syndromes, acute myeloid leukemia or chronic myelomonocytic leukemia
    Meers, S.
    Selleslag, D.
    Potier, H.
    Glasmacher, A.
    Mineur, P.
    Voelter, V.
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (01) : 35 - 42
  • [9] INFECTIOUS COMPLICATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES/ACUTE MYELOID LEUKEMIA TREATED WITH 5-AZACITIDINE
    Ramos, S.
    Santos, M.
    Tenreiro, R.
    Pereira, M.
    Cortesao, E.
    Rito, L.
    Ribeiro, M. L.
    HAEMATOLOGICA, 2015, 100 : 474 - 475
  • [10] SINGLE INSTITUTION EXPERIENCE OF 5-AZACITIDINE THERAPY IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA
    Freyrie, A.
    Guidotti, F.
    Reda, G.
    Binda, F.
    Cortelezzi, A.
    HAEMATOLOGICA, 2012, 97 : 587 - 587
12345